Search

Your search keyword '"Sweet Syndrome prevention & control"' showing total 1 results
Start Over Descriptor "Sweet Syndrome prevention & control" Journal leukemia lymphoma

Refine your results

1 results on '"Sweet Syndrome prevention & control"'

1. Successful use of very low dose subcutaneous decitabine to treat high-risk myelofibrosis with Sweet syndrome that was refractory to 5-azacitidine.

Author

Liu Y, Tabarroki A, Billings S, Visconte V, Rogers HJ, Hasrouni E, Englehaupt R, Kalaycio M, Sekeres MA, Saunthararajah Y, and Tiu RV

Subjects
Antimetabolites, Antineoplastic administration & dosage, Antimetabolites, Antineoplastic adverse effects, Antimetabolites, Antineoplastic therapeutic use, Azacitidine administration & dosage, Azacitidine analysis, Azacitidine therapeutic use, Decitabine, Dose-Response Relationship, Drug, Humans, Injections, Subcutaneous, Male, Middle Aged, Primary Myelofibrosis complications, Risk Factors, Sweet Syndrome chemically induced, Sweet Syndrome complications, Treatment Outcome, Azacitidine adverse effects, Azacitidine analogs & derivatives, Primary Myelofibrosis drug therapy, Sweet Syndrome prevention & control
Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results